EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Successful treatment of Darier's disease with apremilast and review of reported cases

Yusuke Muto iD, Kengo Kinjyo, Yoshihide Asano iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17392 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Yusuke Muto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, South Miyagi Medical Center, Sibata, Japan. Hauptthemen laut MEDLINE: Darier Disease, Thalidomide, Mutation, Missense, Sarcoplasmic Reticulum Calcium-Transporting ATPases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Darier's disease (DD) is a rare autosomal dominant genetic disorder caused by a mutation in ATP2A2 , which encodes calcium (Ca 2+ ) ATPase pumps in the endoplasmic reticulum. In this report, we present the first documented case in Japan successfully treated with apremilast. An 18‐year‐old female presented with red or brown hyperkeratotic papules and plaques on her head, neck, and chest. Histopathological examination revealed a hyperkeratotic, acanthotic epidermis, along with suprabasal acantholysis characterized by corps ronds and grains. Exome sequencing of DNA from peripheral blood mononuclear cells identified a missense mutation in ATP2A2 . Based on the above results, we diagnosed her with DD despite the absence of a family history. Given the effectiveness of apremilast, a phosphodiesterase 4 inhibitor, in treating Hailey‐Hailey disease (HHD), a genetically related disorder involving ATPases in epidermal calcium channels, we opted for apremilast therapy. Eight weeks post‐initiation, significant improvement was observed in the patient's skin lesions on the head, neck, and chest. In this paper, we discuss the successful treatment of DD and HHD cases with apremilast, providing insights into its therapeutic potential, and offer a comprehensive review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Darier DiseaseThalidomideMutation, MissenseSarcoplasmic Reticulum Calcium-Transporting ATPasesHumansFemaleAdolescentTreatment OutcomeSkinPhosphodiesterase 4 InhibitorsAnti-Inflammatory Agents, Non-SteroidalJapan

Stichwörter der Autor:innen

Darier's diseaseHailey‐Hailey diseaseapremilast

Substanzen

apremilastThalidomideSarcoplasmic Reticulum Calcium-Transporting ATPasesATP2A2 protein, humanPhosphodiesterase 4 InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Dermatology, South Miyagi Medical Center, Sibata, Japan.
  • Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Yusuke Muto, Yoshihide Asano

Zitieren

APA

Muto, Y., Kinjyo, K., & Asano, Y. (2025). Successful treatment of Darier's disease with apremilast and review of reported cases. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17392

Vancouver

Muto Y, Kinjyo K, Asano Y. Successful treatment of Darier's disease with apremilast and review of reported cases. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17392

BibTeX
@article{Muto2025,
  author = {Muto, Yusuke and Kinjyo, Kengo and Asano, Yoshihide},
  title = {Successful treatment of Darier's disease with apremilast and review of reported cases},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17392}
}
Kostenlos starten →